“…The Expanded Prostate Cancer Index-26 (EPIC-26) is an international, well-validated questionnaire including urinary, bowel, sexual, and hormonal symptoms for evaluating PROMs in men with PC [6] . Earlier publications reporting on late effects in patients receiving SRT often lack clinical information before surgery to longitudinally elucidate the impact from both surgery and subsequent radiation therapy on adverse health outcomes (AHOs) [5] , [6] , [7] , [8] , [9] , [10] .…”